Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UNK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ARMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STIL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TCF4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMX3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIER1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RRM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FANCL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STAM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNX6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFATC2IP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YTHDC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC126 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RYK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAPG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMD12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAMP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on